Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Tenax Therapeutics (NASDAQ:TENX) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:30 AM.
Here's what investors need to know about the announcement.
Tenax Therapeutics missed estimated earnings by -45.0%, reporting an EPS of $-11.84 versus an estimate of $-8.14.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $1.6 which was followed by a 19.0% drop in the share price the next day.
To track all earnings releases for Tenax Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: TENX